Compare Bio Protocol (BIO) vs Inspect (INSP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Inspect — how do they compare? Bio Protocol trades at Rp432.84 (market cap Rp969,79M, Rp153,24M 24h volume), while Inspect trades at Rp10.84 (market cap Rp7,66M, Rp3,14M 24h volume). The key difference: Bio Protocol is far larger — about 126.6× Inspect's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 798,4M / 1B INSP (80%) for Inspect. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Inspect for 18 Days on average.
| BIO | INSP | |
|---|---|---|
Market Cap | Rp969,79M | Rp7,66M |
Volume (24h) | Rp153,24M | Rp3,14M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 798,4M / 1B INSP (80%) |
Typical Hold Time | 18 Days | 18 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
INSP token maintains a modest market cap of Rp7.66M with 80% of its 1M max supply in circulation. The token shows limited market activity with an average hold time of 18 days, indicating relatively stable holding patterns among current investors. Recent trading data shows minimal price volatility and low volume, suggesting quiet market conditions without significant technical catalysts or protocol developments driving momentum.
Overall outlook remains neutral with limited near-term catalysts. Key opportunity lies in potential ecosystem growth if development activity increases, while major risks include low liquidity and minimal market interest. Investors should monitor for any protocol updates or exchange listings that could impact token utility and trading volume.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Inspect
Inspect is a Layer 2 protocol suite for Bittensor, designed to facilitate scalable financial activities on TAO. It supports a coordinated ecosystem of products, including TaoFlow (yield and leverage), Substrike (mining pools), NeuralGate (cross-chain access), and taoUSD (stablecoin liquidity). These products benefit users, agents, and protocols involved in decentralized AI. Inspect connects AI, capital, and community to spur genuine economic activity around TAO.
Read more on INSP →
